Incidence of Veno-Occlusive Disease in Patients with Neuroblastoma Treated with Autologous Stem Cell Transplantation After Chemoimmunotherapy with Temozolomide, Irinotecan, and Dinutuximab Beta

Urszula Żebrowska, Walentyna Balwierz, Jolanta Goździk, Aleksandra Krasowska-Kwiecień, Agnieszka Dłużniewska, Monika Richert-Przygońska, Krzysztof Czyżewski, Robert Dębski, Monika Pogorzała, Jan Styczyński, Marek Ussowicz, Agnieszka Sokół, Krzysztof Kałwak, Iwona Malinowska, Michał Romiszewski, Hanna Mańko-Glińska, Wanda Badowska, Tomasz Brzeski, Iwona Świerczek-Skwierawska, Szymon Skoczeń, Aleksandra Wieczorek

Open source

DOI: 10.3390/cancers18182912
Published: 2026-09-09
Container: Cancers
Publisher: MDPI AG
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/cancers18182912,
  title = {Incidence of Veno-Occlusive Disease in Patients with Neuroblastoma Treated with Autologous Stem Cell Transplantation After Chemoimmunotherapy with Temozolomide, Irinotecan, and Dinutuximab Beta},
  author = {Urszula Żebrowska and Walentyna Balwierz and Jolanta Goździk and Aleksandra Krasowska-Kwiecień and Agnieszka Dłużniewska and Monika Richert-Przygońska and Krzysztof Czyżewski and Robert Dębski and Monika Pogorzała and Jan Styczyński and Marek Ussowicz and Agnieszka Sokół and Krzysztof Kałwak and Iwona Malinowska and Michał Romiszewski and Hanna Mańko-Glińska and Wanda Badowska and Tomasz Brzeski and Iwona Świerczek-Skwierawska and Szymon Skoczeń and Aleksandra Wieczorek},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18182912},
  url = {https://doi.org/10.3390/cancers18182912}
}

RIS

TY  - JOUR
TI  - Incidence of Veno-Occlusive Disease in Patients with Neuroblastoma Treated with Autologous Stem Cell Transplantation After Chemoimmunotherapy with Temozolomide, Irinotecan, and Dinutuximab Beta
AU  - Urszula Żebrowska
AU  - Walentyna Balwierz
AU  - Jolanta Goździk
AU  - Aleksandra Krasowska-Kwiecień
AU  - Agnieszka Dłużniewska
AU  - Monika Richert-Przygońska
AU  - Krzysztof Czyżewski
AU  - Robert Dębski
AU  - Monika Pogorzała
AU  - Jan Styczyński
AU  - Marek Ussowicz
AU  - Agnieszka Sokół
AU  - Krzysztof Kałwak
AU  - Iwona Malinowska
AU  - Michał Romiszewski
AU  - Hanna Mańko-Glińska
AU  - Wanda Badowska
AU  - Tomasz Brzeski
AU  - Iwona Świerczek-Skwierawska
AU  - Szymon Skoczeń
AU  - Aleksandra Wieczorek
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18182912
UR  - https://doi.org/10.3390/cancers18182912
ER  -

APA

Żebrowska, U., Balwierz, W., Goździk, J., Krasowska-Kwiecień, A., Dłużniewska, A., Richert-Przygońska, M., Czyżewski, K., Dębski, R., Pogorzała, M., Styczyński, J., Ussowicz, M., Sokół, A., Kałwak, K., Malinowska, I., Romiszewski, M., Mańko-Glińska, H., Badowska, W., Brzeski, T., Świerczek-Skwierawska, I., Skoczeń, S., & Wieczorek, A. (2026). Incidence of Veno-Occlusive Disease in Patients with Neuroblastoma Treated with Autologous Stem Cell Transplantation After Chemoimmunotherapy with Temozolomide, Irinotecan, and Dinutuximab Beta. Cancers. https://doi.org/10.3390/cancers18182912

Source records

crossref · retrieved 2026-09-27T02:01:44.875Z